Edition:
United Kingdom

Soleno Therapeutics Inc (SLNO.OQ)

SLNO.OQ on NASDAQ Stock Exchange Capital Market

1.80USD
13 Dec 2017
Change (% chg)

$-0.02 (-1.10%)
Prev Close
$1.82
Open
$1.81
Day's High
$1.88
Day's Low
$1.64
Volume
25,934
Avg. Vol
21,496
52-wk High
$6.50
52-wk Low
$1.35

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Anish Bhatnagar

49 2017 President, Chief Executive Officer, Interim Principal Financial and Accounting Officer, Director

Jonathan Wolter

67 2017 Interim Chief Financial Officer

Anthony Wondka

55 2013 Vice President - Research and Development

Ernest Mario

78 2014 Chairman of the Board

Edgar Engleman

71 2001 Director